Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 9,273 shares at $4.78 ($44K) on 2026-09-15, disclosed to the SEC on 2026-09-15.
Seasonal sale ($44k) by CEO, Medicare Advantage — this insider has traded CLOV in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CLOV | SELL | 2026-09-18 | $9K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |
| CLOV | SELL | 2026-07-16 | $61K | — | Filing → |